A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.
Clinical trial NCT00738257 · COMPLETED
Trial details
- NCT number
- NCT00738257
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2000-06-01
- Primary completion
- 2004-12-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.